Precision Medicine News and Research

RSS

UT Southwestern receives grant to establish Center for Patient-Centered Outcomes Research

UT Southwestern Medical Center has been funded to establish a Center for Patient-Centered Outcomes Research that supports and conducts high-quality research comparing the outcomes and effectiveness of different strategies to prevent, diagnose, treat, and monitor health conditions to improve patient care.

18 Feb 2014

Advanced Accelerator Applications successfully completes capital increase of €41 million

Advanced Accelerator Applications, a fast growing international specialist in Molecular Nuclear Medicine (MNM), announced today that it had successfully completed a capital increase of €41 million.

17 Feb 2014

CHOP develops unique laboratory test to characterize genes that encode HLA molecules

Immunogenetics experts at The Children's Hospital of Philadelphia (CHOP) have developed a unique laboratory test to characterize the genes that encode HLA molecules. The test relies on faster, more comprehensive gene sequencing technology to type human leukocyte antigens (HLAs)--complex, highly variable proteins on cell surfaces that are essential to immune function.

13 Feb 2014

Experts to meet in Biovision's annual forum to discuss effects of disruptive innovation in healthcare

Biovision, the annual forum devoted to future-oriented research in life sciences, is launching this years’ registration campaign and its call for applications for innovative projects and companies. This year’s event will take place in Lyon, France, on June 5 and 6, 2014.

12 Feb 2014

GenomOncology collaborates with RPCI to develop informatics solution for Next Generation Sequencing

GenomOncology today announced a collaboration with Roswell Park Cancer Institute (RPCI) to develop an informatics solution that enables the association of Next Generation Sequencing results with knowledge resources to define actionable mutations.

11 Feb 2014

Covaris introduces truXTRAC High Throughput FFPE DNA Extraction & Purification Kit at 2014 AGBT

Covaris, Inc. introduced the truXTRAC™ High Throughput FFPE DNA Extraction & Purification Kit at the 2014 Advances in Genome Biology and Technology (AGBT) meeting held in Marco Island, Florida.

11 Feb 2014

Researchers design microfluidic platform to see how cancer cells invade specific organs

Nearly 70 percent of patients with advanced breast cancer experience skeletal metastasis, in which cancer cells migrate from a primary tumor into bone - a painful development that can cause fractures and spinal compression.

7 Feb 2014

Study provides evidence for importance of omega-3 fatty acids in healthy brain development

Monkeys that ate a diet rich in omega-3 fatty acids had brains with highly connected and well organized neural networks - in some ways akin to the neural networks in healthy humans - while monkeys that ate a diet deficient in the fatty acids had much more limited brain networking, according to an Oregon Health & Science University study.

5 Feb 2014

Biotheranostics launches complete genomic tests for metastatic cancer patients

bioTheranostics, Inc., today introduced the bioT3 Metastatic Cancer Solution, a suite of genomic-based tests that provide personalized diagnostic information and therapeutic guidance for metastatic cancer patients across the continuum of care.

4 Feb 2014

NeoGenomics validates and launches series of NeoTYPE cancer profiling tests

NeoGenomics, Inc., a leading provider of cancer-focused genetic and molecular testing services, announced today that it has validated and launched a series of NeoTYPE cancer profiling tests covering 22 different categories of cancer. Each of these tests is designed to investigate the most common and actionable genomic abnormalities reported for that particular tumor.

30 Jan 2014

South Korean lung SCC genetic secrets revealed

Close examination of DNA taken from squamous cell carcinoma of the lung in South Korean patients has identified a gene fusion that may be targeted by current treatments, scientists say.

27 Jan 2014

DKFZ, AstraZeneca EORTC join Worldwide Innovative Network Consortium

The Worldwide Innovative Network (WIN) Consortium in personalized cancer medicine is proud to announce that AstraZeneca, DKFZ and EORTC have joined the Consortium.

27 Jan 2014

Researchers identify five new genes associated with increased waist-to-hip ratio

Excess abdominal fat can be a precursor to diseases such as cardiovascular disease, type 2 diabetes and cancer. A person's measure of belly fat is reflected in the ratio of waist circumference to hip circumference, and it is estimated that genetics account for about 30-60 percent of waist-to-hip ratio.

23 Jan 2014

MD Anderson collaborates with Johnson & Johnson to develop immunology-based cancer treatments

The University of Texas MD Anderson Cancer Center will collaborate with Johnson & Johnson Innovation, LLC, and its affiliate Janssen Biotech, Inc., to develop immunology-based cancer treatments through the MD Anderson Moon Shots Program immunotherapy platform.

23 Jan 2014

Tumor profiling study of colorectal cancer to be presented at 2014 Gastrointestinal Cancers Symposium

Caris Life Sciences, a leading biosciences company focused on fulfilling the promise of personalized medicine, will present a large international tumor profiling study of colorectal cancer at the 2014 Gastrointestinal Cancers Symposium this week in San Francisco, Calif. With more than 7,000 patients comprehensively profiled by Caris Molecular Intelligence, this study represents the largest, multi-national analysis in a single laboratory setting of the main molecular anomalies in colorectal cancer.

18 Jan 2014

Professor wins NSF CAREER grant to develop 5-D in vivo image of atherosclerotic plaques

Currently, the medical community has limited ability in clinically assessing blockages called atherosclerotic plaques in the human body. These dangerous blockages that can lead to heart attacks and strokes are not easily diagnosed due to "the lack of noninvasive imaging techniques to accurately model atherosclerotic plaques in vivo," said Guohua Cao, assistant professor of biomedical engineering at Virginia Tech.

17 Jan 2014

Transgenomic, Horizon Discovery collaborate to develop improved genetic diagnostic tests with state of art controls

Transgenomic, Inc. (OTCBB: TBIO), a global biotechnology company advancing personalized medicine in cardiology, oncology, and inherited diseases through diagnostic tests as well as clinical and research services, and Horizon Discovery Ltd. (Horizon), a leading provider of research tools to support translational genomics and the development of personalized medicines, today announced they have entered into a collaboration agreement to develop improved genetic diagnostic tests incorporating state of the art controls.

16 Jan 2014

Precision Medicine News and Research

UT Southwestern receives grant to establish Center for Patient-Centered Outcomes Research

Advanced Accelerator Applications successfully completes capital increase of €41 million

CHOP develops unique laboratory test to characterize genes that encode HLA molecules

Experts to meet in Biovision's annual forum to discuss effects of disruptive innovation in healthcare

GenomOncology collaborates with RPCI to develop informatics solution for Next Generation Sequencing

Covaris introduces truXTRAC High Throughput FFPE DNA Extraction & Purification Kit at 2014 AGBT

Researchers design microfluidic platform to see how cancer cells invade specific organs

Study provides evidence for importance of omega-3 fatty acids in healthy brain development

Biotheranostics launches complete genomic tests for metastatic cancer patients

NeoGenomics validates and launches series of NeoTYPE cancer profiling tests

South Korean lung SCC genetic secrets revealed

DKFZ, AstraZeneca EORTC join Worldwide Innovative Network Consortium

Researchers identify five new genes associated with increased waist-to-hip ratio

MD Anderson collaborates with Johnson & Johnson to develop immunology-based cancer treatments

Tumor profiling study of colorectal cancer to be presented at 2014 Gastrointestinal Cancers Symposium

Professor wins NSF CAREER grant to develop 5-D in vivo image of atherosclerotic plaques

Transgenomic, Horizon Discovery collaborate to develop improved genetic diagnostic tests with state of art controls

Scientists develop novel treatment for Hairy Cell Leukaemia using drug administered to combat skin cancer

Weill Cornell Medical College received a $75M grant to expand, enhance cancer research, care programs

Plasma thermogram can serve as an indicator of cervical cancer

Event guide: The 4th Precision Medicine in Inflammatory Bowel Disease Summit eBook

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

How Omics Technologies Are Transforming Biological Research and Drug Discovery

Latest News